by Don McLean | Nov 5, 2019 | Blog
Pharmaceutical Industry News Roundup: October 2019 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from last month: Researchers find 15% of trials could be replicated using real world...
by Don McLean | Oct 3, 2019 | Blog
Webinar: The Programmers Approach to Real World Data and Using Real World Evidence in Research and Healthcare by MMS Holdings and MichBio.org This webinar is intended to help guide individuals towards a better understanding of core concepts and requirements for using...
by Don McLean | Aug 22, 2019 | Blog
Using Real World Data in Drug Development: Five Questions with Vijay Ivaturi by Staff Writer The idea and practice of using real world data in the pharmaceutical industry has driven much conversation as of late. As groups like the Health Analytics Collective begin to...
by Don McLean | Jun 13, 2019 | Blog
Developing Treatments for Rare Diseases – Reviewing Draft Guidance from the FDA by Amanda Beaster, PhD, Andrew Chervenak, PhD, Halina Chkourko Gusky, PhD, and Ingrid Hansen, MS New and updated regulatory guidances from the US Food and Drug Administration (FDA),...
by Don McLean | Feb 28, 2019 | Blog
How #OneMMS Actively Supports Rare Disease Day by Staff writer Rare diseases are often overlooked, but they affect many individuals. There may be as many as 7,000 rare diseases affecting approximately 25-30 million people in the US alone, according to the National...
